New Delhi: Doctors have raised concerns over the growing popularity of injectable peptides for weight loss, muscle recovery, anti-ageing and longevity, warning that the success of a few scientifically established peptide medicines should not be confused with the safety or efficacy of experimental compounds being promoted online.
The concerns have come into focus after a proposed “Peptide Party” in Bengaluru was cancelled following regulatory intervention, highlighting a wider trend of people exploring peptide-based therapies outside conventional medical settings.
Peptides are short chains of amino acids that act as signalling molecules in the body. While medicines such as insulin and GLP-1-based drugs have well-established medical applications, several compounds popular in the biohacking and longevity space have limited human evidence.
Dr Naval K Vikram, professor in the Department of Medicine at AIIMS, Delhi and an expert in metabolic disorders, said the growing interest in peptides needed to be viewed with caution, particularly when consumers begin to equate all peptides with established drugs.
He emphasised that they should not be used without medical supervision.
“Peptides are not one homogeneous group of medicines. Some have undergone extensive clinical research and are routinely used in medicine, while others are still experimental.
“The fact that semaglutide or another peptide-based drug works does not mean that every peptide being sold for weight loss, muscle recovery or longevity will have the same safety and efficacy,” Vikram said.
He said the use of such compounds should be guided by quality of evidence, regulatory status and the patient’s individual medical condition rather than social media claims or anecdotal experiences.
Aman Puri, founder of sports and wellness brand, Steadfast Nutrition, said the growing influence of social media influencers, celebrities and the wellness industry has made consumers increasingly willing to experiment with injectable and unapproved peptides promising greater longevity, sharper cognition and better sleep.
“The larger concern is when wellness trends start replacing evidence-based decision making. Consumers need to understand what they are taking, why they are taking it and whether there is credible human evidence behind the claim,” Puri said.
He said the quality and source of a product were equally important, particularly when it involved injectable preparations. Such products should only be taken if prescribed by a doctor and under medical supervision.
“While the safety and efficacy of certain oral peptide supplements is supported by research, these should not be treated as substitutes for a balanced diet and should be taken after consultation with a healthcare professional,” Puri stated.
Dr Ravinder Goswami, professor in the Endocrinology at AIIMS, Delhi, said the biggest misconception was that the word “peptide” itself represented a guarantee of safety.
“Peptide is a chemical and biological category, not a certificate of safety. Two peptides can have completely different mechanisms, indications, doses and adverse-effect profiles. A compound that looks promising in laboratory or animal studies cannot automatically be recommended for use in humans,” the senior endocrinologist said.
Goswami said self-injection was particularly concerning as users may not know whether a product contains the stated compound or concentration and may also mishandle storage, dilution or administration.
“Once an experimental compound is injected, you are exposing the entire body to it. With products that lack adequate human safety data, we may simply not know the consequences of prolonged use or of combining several such compounds,” he said.
He also cautioned against “peptide stacking“, in which people combine multiple compounds based on recommendations circulating in online fitness and biohacking communities.
Functional medicine practitioner Mugdha Pradhan, founder of iThrive, a health and wellness company, said the peptide conversation should not be reduced to a simple question of whether peptides were “good” or “bad”.
“There is genuine science behind peptide biology and there are peptide therapies with important clinical applications. But the conversation needs to move beyond marketing and ask what evidence exists for a particular peptide, what problem it is being used for and whether its use is appropriate for that individual,” she said.
Pradhan said consumers should also be wary of treating emerging therapies as quick fixes for complex metabolic or ageing-related problems.
The Bengaluru episode has highlighted how rapidly the peptide conversation is moving from specialist medical settings into the wider wellness ecosystem.
Doctors said the popularity of semaglutide and tirzepatide had likely contributed to the perception that “peptides” were synonymous with weight loss and rapid health benefits. However, established drugs have gone through clinical trials, regulatory scrutiny, quality-controlled manufacturing and post-marketing monitoring, they noted.
Experts said consumers considering peptide-based treatment should therefore consult a qualified doctor and verify the product’s regulatory status, source, composition and intended indication rather than relying on influencers, online communities or anecdotal success stories.
